European Respiratory Society Monograph, Vol. 45. 2009
ISBN: 978-1-904097-70-9
Lung transplantation is a treatment option for selected patients who are not responding to maximal medical therapy, or for whom no effective medical therapy exists. This book provides a comprehensive guide to the recent advances in lung transplantation, and includes coverage of donor selection, immunosuppression, infectious and noninfectious complications, and management of bronchiolitis obliterans syndrome and post-transplant lymphoproliferative disease emerging after lung transplantation.
The Guest Editors
Eur Respir Mon; 2009: 45: vii |  |
Preface
Eur Respir Mon; 2009: 45: viii |  |
Introduction G.M. Verleden, A.J. Fisher, G. Massard Eur Respir Mon; 2009: 45: ix-x |  |
Indication, patient selection and timing of referral for lung transplantation G.M. Verleden, A.J. Fisher Eur Respir Mon; 2009: 45: 1–5 |  |
Pulmonary hypertension M. Delcroix, P.A. Corris Eur Respir Mon; 2009: 45: 9–24 |  |
Chronic obstructive pulmonary disease G.I. Snell Eur Respir Mon; 2009: 45: 25–31 |  |
Cystic fibrosis C. Knoop, L.J. Dupont Eur Respir Mon; 2009: 45: 32–45 |  |
Pulmonary fibrosis W.A. Wuyts, S. Ryan, J.J. Egan Eur Respir Mon; 2009: 45: 46–53 |  |
Pre-transplant management of co-existing diseases M. Carby Eur Respir Mon; 2009: 45: 54–61 |  |
Osteoporosis in end-stage lung disease E. Kochetkova Eur Respir Mon; 2009: 45: 62–78 |  |
Donor selection P. Botha, J.H. Dark, A.J. Fisher Eur Respir Mon; 2009: 45: 81–87 |  |
Allocation of donor lungs J.M.A. Smits, W. van der Bij, A.O. Rahmel Eur Respir Mon; 2009: 45: 88–103 |  |
Increasing the donor pool D.E.M. Van Raemdonck, G.M. Verleden, W. Coosemans, H. Decaluwé, G. Decker, P. De Leyn, P. Nafteux, T. Lerut Eur Respir Mon; 2009: 45: 104–127 |  |
Early peri-operative care F. Meloni, M. Strueber Eur Respir Mon; 2009: 45: 131–146 |  |
Immunosuppression M. Iversen, P.A. Corris Eur Respir Mon; 2009: 45: 147–168 |  |
Infectious complications F.K. Gould, E.A.M. Verschuuren, G.M. Verleden Eur Respir Mon; 2009: 45: 169–176 |  |
Noninfectious complications G. Massard, N. Santelmo, P-E. Falcoz, R. Kessler Eur Respir Mon; 2009: 45: 177–193 |  |
Bronchiolitis obliterans syndrome G.M. Verleden, A.J. Fisher, A. Boehler, M. Estenne Eur Respir Mon; 2009: 45: 197–211 |  |
Emerging risk factors for bronchiolitis obliterans syndrome: gastro-oesophageal reflux and infections L.J. Dupont, F. D'Ovidio Eur Respir Mon; 2009: 45: 212–225 |  |
Post-transplant lymphoproliferative disease and other malignancies E.A.M. Verschuuren Eur Respir Mon; 2009: 45: 226–237 |  |
Outcome and functional results W. van der Bij, M. Reynaud-Gaubert Eur Respir Mon; 2009: 45: 238–250 |  |
Paediatric aspects of lung transplantation C. Benden, P. Aurora Eur Respir Mon; 2009: 45: 251–265 |  |
Future prospects G. Massard Eur Respir Mon; 2009: 45: 266-269 |  |